Filta Group Holdings PLC – FLTA – Trading Update
Filta Group Holdings PLC (AIM: FLTA), a provider of fryer management and other services to commercial kitchens, provides the following update on its trading.
Filta Group Holdings PLC (AIM: FLTA), a provider of fryer management and other services to commercial kitchens, provides the following update on its trading.
Brave Bison, the social media and marketing group, is pleased to announce that Theo Green will join the Board as Executive Director, with immediate effect. Theo has been serving as the Company’s Director of Growth since June 2020 and is a director of Brave Bison Limited, a subsidiary of the Company.
The Board of RTC is pleased to provide a positive trading update for its financial year ended 31 December 2019, advising that it is trading in line with current market expectations.
Surface Transforms (AIM: SCE) provides the following trading update for the seven months to 31 December 2019, being the end of the new truncated financial year as announced on 15 August 2019.
Trackwise Designs Plc (AIM: TWD), a leading provider of specialist products using printed circuit technology, has signed a Collaboration Agreement with GKN Aerospace, (“GKN”), the world’s leading multi-technology tier 1 aerospace supplier, for the industrialisation of GKN Aerospace Type 8 Ice Protection System.
Integumen today announces that LabskinAI has signed new agreements with two of the Top-10 global cosmetic companies for initial testing on ingredients and products in their portfolio.
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, has developed proof of concept workflows to analyse in real-time complex samples from bioreactors, which could enable customers to achieve significant costs and time savings.
Advanced Oncotherapy (AIM: AVO), the developer of a next-generation proton therapy system for cancer treatment, announces positive results from its comparative study which further demonstrates the competitive advantages of the LIGHT system, the Company’s proprietary proton accelerator.
ANGLE plc (AIM:AGL), a world-leading liquid biopsy company, is pleased to announce that top US cancer centre, the University of Texas MD Anderson Cancer Center has developed a new technique for assessing the metastatic potential of breast cancer using ANGLE’s ParsortixTM system.